Mingyi Sun
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Cell death mechanisms and regulation 3
- Natural product bioactivities and synthesis 3
- Epigenetics and DNA Methylation 2
-
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 3
- Immunotherapy and Immune Responses 2
- Co-authors
- Pamela J. Fink (4 shared papers)Chen Dong (1 shared paper)Alexander Y. Rudensky (1 shared paper)Durbaka V. R. Prasad (1 shared paper)Jian Ni (9 shared papers)Xingbin Yin (8 shared papers)Xiaoxv Dong (5 shared papers)Longtai You (7 shared papers)
- Journals
- The Journal of Immunology (5 papers)Frontiers in Pharmacology (2 papers)Biomedicine & Pharmacotherapy (2 papers)Scientific Reports (1 paper)International Journal of Nanomedicine (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Mingyi Sun
19 papers receiving 980 citations
Peers
Comparison fields: 5 of 95
- Immunology 371
- Oncology 204
- Cancer Research 80
- Hematology 60
- Pharmacology 47
Countries citing papers authored by Mingyi Sun
This map shows the geographic impact of Mingyi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Sun more than expected).
Fields of papers citing papers by Mingyi Sun
This network shows the impact of papers produced by Mingyi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Sun. The network helps show where Mingyi Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingyi Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 242 | |
| 2 | 2007 | 108 | |
| 3 | 2011 | 103 | |
| 4 | 2020 | 86 | |
| 5 | 2020 | 77 | |
| 6 | 2006 | 54 | |
| 7 | 2021 | 44 | |
| 8 | 2019 | 43 | |
| 9 | 2017 | 42 | |
| 10 | 2020 | 39 | |
| 11 | 2020 | 31 | |
| 12 | 2007 | 26 | |
| 13 | 2004 | 24 | |
| 14 | 2016 | 23 | |
| 15 | 2019 | 23 | |
| 16 | 2020 | 13 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 2 | |
| 19 | 2022 | 1 |
About Mingyi Sun
Mingyi Sun is a scholar working on Molecular Biology, Immunology, Plant Science, Oncology and Complementary and alternative medicine, having authored 19 papers that have together received 990 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (3 papers), Cell death mechanisms and regulation (3 papers), Natural product bioactivities and synthesis (3 papers), Phytochemistry and biological activity of medicinal plants (2 papers), Traditional Chinese Medicine Analysis (2 papers), Epigenetics and DNA Methylation (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Immunology (371 citations), Oncology (204 citations), Cancer Research (80 citations), Hematology (60 citations) and Pharmacology (47 citations). Mingyi Sun has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Pamela J. Fink, Chen Dong, Alexander Y. Rudensky, Durbaka V. R. Prasad, Jian Ni, Xingbin Yin, Xiaoxv Dong, Longtai You, Wenping Wang and Kristina Ames. Their work appears in journals such as The Journal of Immunology, Frontiers in Pharmacology, Biomedicine & Pharmacotherapy, Scientific Reports and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.